Development of [C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

نویسندگان

  • Idris Bahce
  • Egbert F. Smit
  • Mark Lubberink
  • Astrid A. M. van der Veldt
  • Maqsood Yaqub
  • Albert D. Windhorst
  • Robert C. Schuit
  • Erik Thunnissen
  • A. M. Heideman
  • Pieter E. Postmus
  • Adriaan A. Lammertsma
  • Harry Hendrikse
چکیده

Purpose: To evaluate whether, in patients with non–small cell lung carcinoma (NSCLC), tumor uptake of [C]erlotinib can be quantified and imaged using positron emission tomography and to assess whether the level of tracer uptake corresponds with the presence of activating tumor EGF receptor

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Imaging, Diagnosis, Prognosis Development of [C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

Purpose: To evaluate whether, in patients with non–small cell lung carcinoma (NSCLC), tumor uptake of [C]erlotinib can be quantified and imaged using positron emission tomography and to assess whether the level of tracer uptake corresponds with the presence of activating tumor EGF receptor

متن کامل

Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.

PURPOSE To evaluate whether, in patients with non-small cell lung carcinoma (NSCLC), tumor uptake of [(11)C]erlotinib can be quantified and imaged using positron emission tomography and to assess whether the level of tracer uptake corresponds with the presence of activating tumor EGF receptor (EGFR) mutations. EXPERIMENTAL DESIGN Ten patients with NSCLCs, five with an EGFR exon 19 deletion, a...

متن کامل

Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [11C]erlotinib PET

BACKGROUND Non-small cell lung carcinoma (NSCLC) represents approximately 80% of lung cancer cases, and over 60% of these tumors express the epidermal growth factor receptor (EGFR). Activating mutations in the tyrosine kinase (TK) domain of the EGFR are detected in 10% to 30% of NSCLC patients, and evidence of their presence is a prerequisite for initiation of first-line therapy with selective ...

متن کامل

An overview on Ga-68 radiopharmaceuticals for positron emission tomography applications

Gallium-68 a positron emitter radionuclide, with great impact on the nuclear medicine, has been widely used in positron emission tomography (PET) diagnosis of various malignancies in humans during more recent years especially in neuroendocrine tumors (NETs). The vast number of 68Ge/68Ga related generator productions, targeting molecule design (proteins, antibody fragments,...

متن کامل

Detection of Alzheimer\\\\\\\'s Disease using Multitracer Positron Emission Tomography Imaging

Alzheimer's disease is characterized by impaired glucose metabolism and demonstration of amyloid plaques. Individual positron emission tomography tracers may reveal specific signs of pathology that is not readily apparent on inspection of another one. Combination of multitracer positron emission tomography imaging  yields promising results. In this paper, 57 Alzheimer's disease neuroimaging ini...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012